본문 바로가기
KERD
논문KCI 등재

접합 가능한 다제내성 녹농균의 출현

Emergence of Conjugative Multidrug-Resistant Pseudomonas aeruginosa

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류생물학

초록

다제내성 P. aeruginosa (MRPA)의 출현과 확산은 전 세계적으로 심각한 문제가 되었다. 특히 metallo-β-lactamases (MBLs)의 carbapenem 고도내성 관여 정도는 심각한 수준이며, 특히 P. aeruginosa는 장내세균 속 균종과는 달리 새로운 클론들이 지속적으로 나타나고 기존에 확산되었던 우세 클론을 대체하는 과정이 매우 빠르게 진행되고 있다. 이에 본 연구에서는 2017년 9월부터 2019년 9월까지 부산의한 종합병원에서 다양한 의료용 시료로부터 분리된 18균주의 P. aeruginosa 균주에 대한 항균제 내성 유전자 분석과DNA 염기서열 분석을 통한 Integron의 유전자 카세트 분석 및 접합에 의한 Plasmid 전달 분석을 수행하며 이에 대한 역학관계를 조사하고자 하였다. 18균주 모두 XDR 표현형을 보이는 균주였으며, Colistin(100%)을 제외한 대부분의 항생제에 내성을 나타냈으나, aztreonam(22.2%), ceftazidime(16.6%) 에 일부 감수성을 보였다. 균주의 66.7%는 다양한 항균제 내성을 나타내는 Class1 integron을 가지고 있었으며, 접합에의한 Plasmid전달도 성공적으로 이루어졌다(83.3%). 이는이전의 장내세균에 대한 연구결과보다 25.8% 상향한 결과를보여 공중보건에 대한 심각한 역학관점의 고찰을 필요로 한다. 특히, IMP-6 ST235 (66.7%)가 주를 이루며, VIM-2 ST357 (16.7), IMP-1 ST446 (16.7)이 확인되었다. 흥미롭게도, 국내에서는 아직까지 보고된 바가 없는 IMP-1 생성ST446의 확인은 또 다른 MRPA 고위험 클론의 생성과 유행이라는 관점에서 주목할 만하다.

Abstract

The emergence and spread of multidrug-resistant Pseudomonas aeruginosa (MRPA) have become a serious problem worldwide. The involvement of metallo-β-lactamases (MBLs) in inducing carbapenem resistance is particularly acute. However, unlike other members of the Enterobacteriaceae genus, new clones of P. aeruginosa are constantly emerging and rapidly replacing previously prevalent dominant clones. Therefore, this study aimed to perform antimicrobial resistance gene analysis, integron gene cassette analysis using DNA sequencing, and plasmid transfer analysis by conjugation to investigate the antimicrobial resistance dynamics of 18 P. aeruginosa strains isolated from various medical samples at a general hospital in Busan from September 2017 to September 2019. All 18 strains showed extensively drug-resistant (XDR) phenotype and were resistant to most antibiotics, except colistin (100%) but were susceptible to aztreonam (22.2%) and ceftazidime (16.6%). Approximately 66.7% of the strains had Class 1 integrons showing various antimicrobial resistances. Notably, IMP-6 ST235 (66.7%), VIM-2 ST357 (16.7%), and IMP-1 ST446(16.7%) were identified. The identification of IMP-1-producing ST446, previously unreported in Korea, is noteworthy considering the emergence and prevalence of another MRPA high-risk clone.

참고문헌 (66)

  1. Kumari H, "Role of Pseudomonas aeruginosa AmpR on β-lactam and non-β-lactam transient cross-resistance upon pre-exposure to subinhibitory concentrations of antibiotics", J. Med. Microbiol, 63, pp.544~555 (2014)
  2. Fazeli N, "Virulence gene profiles of multidrugresistant Pseudomonas aeruginosa isolated from Iranian hospital infections", Iran Red. Crescent Med. J, 16, pp.e15722~ (2014)
  3. Strateva T, "Pseudomonas aeruginosa-a phenomenon of bacterial resistance", J. Med. Microbiol, 58, pp.1133~1148 (2009)
  4. Yoo JS, "Dissemination of genetically related IMP-6-producing multidrugresistant Pseudomonas aeruginosa ST235 in South Korea", Int. J. Antimicrob. Agents, 39, pp.300~304 (2012)
  5. Wright LL, "Dominance of international 'high-risk clones' among metallo-β-lactamase-producing Pseudomonas aeruginosa in the UK", J. Antimicrob. Chemother, 70, pp.103~110 (2015)
  6. Magiorakos AP, "Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria : an international expert proposal for interim standard definitions for acquired resistance", Clin. Microbiol. Infect, 18, pp.268~281 (2012)
  7. 김도균, "다제내성균 현황", 대한의사협회지, 65(8), pp.468~477 (2022), 대한의사협회[DOI]
  8. Yoon EJ, "Mobile carbapenemase genes in Pseudomonas aeruginosa", Front. Microbiol, 12, pp.614058~ (2021)
  9. Choi JY, "Trends in the distribution and antimicrobial susceptibility of causative pathogens of device-associated infection in Korean intensive care units from 2006 to 2013 : results from the Korean Nosocomial Infections Surveillance System(KONIS)", J. Hosp. Infect, 92, pp.363~371 (2016)
  10. Rasmussen B, "Cloning and sequencing of the class B β-lactamase gene(ccrA)from bacteroides fragilis TAL3636", Antimicrob. Agents Chemother, 34, pp.1590~1592 (1990)
  11. Crespo MP, "Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-β-lactamase, in a tertiary care center in Cali, Colombia", J. Clin. Microbiol, 42, pp.5094~5101 (2004)
  12. Toleman MA, "Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America : report from the SENTRY antimicrobial surveillance programme", J. Antimicrob. Chemother, 50, pp.673~679 (2002)
  13. Cicek AC, "Determination of a novel integron-located variant(blaOXA-320)of Class D β-lactamase in Proteus mirabilis", J. Basic Microbiol, 54, pp.1030~1035 (2014)
  14. Weinstein MP, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically", ~ (2018)
  15. Tsai YM, "Combination of modified carbapenem inactivation method(mCIM)and EDTACIM(eCIM)for phenotypic detection of carbapenemase-producing Enterobacteriaceae", BMC Microbiol, 20, pp.315~ (2020)
  16. Jeong S, "Evaluation of peptide nucleic acid-mediated multiplex real-time PCR kits for rapid detection of carbapenemase genes in gram-negative clinical isolates", J. Microbiol. Methods, 113, pp.4~9 (2015)
  17. Lee Miyoung, "Antimicrobial Resistance Caused by KPC-2 Encoded by Promiscuous Plasmids of the Klebsiella pneumoniae ST307 Strain", Annals of Laboratory Medicine, 41(1), pp.86~94 (2021), 대한진단검사의학회[DOI]
  18. Pérez-Pérez FJ, "Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR", J. Clin. Microbiol, 40, pp.2153~2162 (2002)
  19. Ryoo NH, "Dissemination of SHV-12 and CTX-M-type extended-spectrum β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea", J. Antimicrob. Chemother, 56, pp.698~702 (2005)
  20. Yamane K, "Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan", Antimicrob. Agents Chemother, 52, pp.1564~1566 (2008)
  21. Edalucci E, "Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa", Clin. Microbiol. Infect, 14, pp.88~90 (2008)
  22. Curran B, "Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa", J. Clin. Microbiol, 42, pp.5644~5649 (2004)
  23. Dillon B, "Multiplex PCR for screening of integrons in bacterial lysates", J. Microbiol. Methods, 62, pp.221~232 (2005)
  24. Zhang XX, "Characterization and quantification of class 1 integrons and associated gene cassettes in sewage treatment plants", Appl. Microbiol. Biotechnol, 82, pp.1169~1177 (2009)
  25. Lévesque C, "PCR mapping of integrons reveals several novel combinations of resistance genes", Antimicrob. Agents Chemother, 39, pp.185~191 (1995)
  26. Jeong SH, "Clonal and horizontal spread of the blaOXA-232 gene among Enterobacteriaceae in a Korean hospital", Dia. Microbiol. Infect. Dis, 82, pp.70~72 (2015)
  27. 이미영, "Species Transferability of Klebsiella pneumoniae Carbapenemase-2 Isolated from a High-Risk Clone of Escherichia coli ST410", Journal of Microbiology and Biotechnology, 30(7), pp.974~981 (2020), 한국미생물·생명공학회[DOI]
  28. "Antimicrobial resistance: Tackling a crisis for the health and wealth of nations" (2014)[URL]
  29. "GLASS report: early implementation 2017-2018" (2019)[URL]
  30. Bonomo RA, "Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa", Clin. Infect. Dis, 43, pp.S49~S56 (2006)
  31. Kim J, "Clinical characteristics and risk factors of colistin-induced nephrotoxicity", Int. J. Antimicrob. Agents, 34, pp.434~438 (2009)
  32. Zavascki AP, "Polymyxin B for the treatment of multidrug-resistant pathogens : a critical review", J. Antimicrob. Chemother, 60, pp.1206~1215 (2007)
  33. Lister PD, "Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin", Antimicrob. Agents Chemother, 43, pp.882~889 (1999)
  34. Kang HY, "Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from humans and animals in Korea", J. Antimicrob. Chemother, 55, pp.639~644 (2005)
  35. Wei Q, "A novel functional class 2 integron in clinical Proteus mirabilis isolates", J. Antimicrob. Chemother, 69, pp.973~976 (2014)
  36. Schulz J, "Analysis of fluoroquinolones in dusts from intensive livestock farming and the co-occurrence of fluoroquinoloneresistant Escherichia coli", Sci. Rep, 9, pp.5117~ (2019)
  37. Hopkins KL, "Mechanisms of quinolone resistance in Escherichia coli and Salmonella : recent developments", Int. J. Antimicrob. Agents, 25, pp.358~373 (2005)
  38. Endtz HP, "Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine", J. Antimicrob. Chemother, 27, pp.199~208 (1991)
  39. Dalhoff A, "Global fluoroquinolone resistance epidemiology and implictions for clinical use", Interdiscip. Perspect. Infect. Dis, 2012, pp.976273~ (2012)
  40. Sarkoezy G, "Quinolones : a class of antimicrobial agents", Vet. Med, 46, pp.257~274 (2001)
  41. Grobbel M, "Comparative quantification of the in vitro activity of veterinary fluoroquinolones", Vet. Microbiol, 124, pp.73~81 (2007)
  42. Frye JG, "Genetic mechanisms of antimicrobial resistance identified in Salmonella enterica, Escherichia coli, and Enteroccocus spp. isolated from U.S. food animals", Front. Microbiol, 4, pp.135~ (2013)
  43. García Ovando H, "Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in chickens", J. Vet. Pharmacol. Ther, 22, pp.209~212 (1999)
  44. Van den Bogaard AE, "Antibiotic resistance of faecal Escherichia coli in poultry, poultry farmers and poultry slaughterers", J. Antimicrob. Chemother, 47, pp.763~771 (2001)
  45. Neyestanaki DK, "Determination of extended spectrum β-lactamases, metallo-β-lactamases and AmpC-β-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients", Burns, 40, pp.1556~1561 (2014)
  46. Walsh TR, "Metallo-β-lactamases : the quiet before the storm?", Clin. Microbiol. Rev, 18, pp.306~325 (2005)
  47. Queenan AM, "Carbapenemases : the versatile β-lactamases", Clin. Microbiol. Rev, 20, pp.440~458 (2007)
  48. Tenover FC, "Carbapenemase-producing", Emerg. Microbes Infect, 11, pp.811~814 (2022)
  49. Seok Y, "Dissemination of IMP-6 metallo-β-lactamase-producing Pseudomonas aeruginosa sequence type 235 in Korea", J. Antimicrob. Chemother, 66, pp.2791~2796 (2011)
  50. Lee K, "bla(VIM-2)cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital", Antimicrob. Agents Chemother, 46, pp.1053~1058 (2002)
  51. Chong Y, "Korean nationwide surveillance of antimicrobial resistance of bacteria in 1997", Yonsei Med. J, 39, pp.569~577 (1997)
  52. 이경원, "Increase of Ceftazidime- and Fluoroquinolone-Resistant Klebsiella pneumoniae and Imipenem-Resistant Acinetobacter spp. in Korea: Analysis of KONSAR Study Data from 2005 and 2007", Yonsei Medical Journal, 51(6), pp.901~911 (2010), 연세대학교의과대학
  53. Hong JS, "Clonal dissemination of Pseudomonas aeruginosa sequence type 235 isolates carrying blaIMP-6 and emergence of blaGES-24 and blaIMP-10 on novel genomic islands PAGI-15 and -16 in South Korea", Antimicrob. Agents Chemother, 60, pp.7216~7223 (2016)
  54. 홍준성, "Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in Korea", Infection and Chemotherapy, 47(1), pp.33~40 (2015), 대한감염학회
  55. Hong JS, "Molecular characteristics of GES-type carbapenemase-producing", Microb. Drug Resist, 26, pp.605~610 (2020)
  56. Samuelsen O, "Molecular epidemiology of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion", Antimicrob. Agents Chemother, 54, pp.346~352 (2010)
  57. Cholley P, "Most multidrug-resistant Pseudomonas aeruginosa isolates from hospitals in eastern France belong to a few clonal types", J. Clin. Microbiol, 49, pp.2578~2583 (2011)
  58. Maatallah M, "Population structure of Pseudomonas aeruginosa from five Mediterranean countries : evidence for frequent recombination and epidemic occurrence of CC235", PLoS One, 6, pp.e25617~ (2011)
  59. Giske CG, "Establishing clonal relationships between VIM-1-like metallo-β-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing", J. Clin. Microbiol, 44, pp.4309~4315 (2006)
  60. Pournaras S, "Detection of a phylogenetically distinct IMP-type metallo-β-lactamase, IMP-35, in a CC235 Pseudomonas aeruginosa from the Dutch-German border region(Euregio)", J. Antimicrob. Chemother, 68, pp.1271~1276 (2013)
  61. Pincus NB, "Long-term persistence of an extensively drug-resistant subclade of globally distributed Pseudomonas aeruginosa clonal complex 446 in an academic medical center", Clin. Infect. Dis, 71, pp.1524~1531 (2020)
  62. Geraci DM, "Is the monoclonal spread of the ST258, KPC-3-producing clone being replaced in southern Italy by the dissemination of multiple clones of carbapenem-nonsusceptible, KPC-3-producing Klebsiella pneumoniae? Clin", Microbiol. Infect, 21, pp.e15~ (2015)[DOI]
  63. Roer L, "Escherichia coli sequence type 410 is causing new international high-risk clones", mSphere, 3, pp.e00337~18 (2018)
  64. Smillie C, "Mobility of plasmids", Microbiol. Mol. Biol. Rev, 74, pp.434~452 (2010)
  65. 이미영, "Molecular Analysis of Carbapenem-Resistant Enterobacteriaceae at a South Korean Hospital", 한국미생물·생명공학회지, 48(3), pp.389~398 (2020), 한국미생물·생명공학회[DOI]
  66. Hong JS, "Molecular characterization of the first emerged NDM-1-producing", Microb. Drug Resist, 27, pp.1063~1070 (2021)

관련 논문AI추천

대전지역의 입원환자에서 분리된 Carbapenem 내성 Pseudomonas aeruginosa의 분자역학조사(2008년에서 2014년까지)조혜현대한임상검사과학회 · 대한임상검사과학회지2018 · 제50권 제4호Metallo-β-lactamase 생성 녹농균에서 Class 1 Integron의 유전형 분석고지선, 구선회, 권계철, 박종우, 성지연, 송정훈, 신소연대한임상미생물학회 · Annals of Clinical Microbiology2009 · 제12권 제1호Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in Korea김정옥, 배일권, 이경원, 이혁민, 정석훈, 홍준성대한감염학회 · Infection and Chemotherapy2015 · 제47권 제1호Imipenem 내성 Pseudomonas aeruginosa의 분리 현황과 내성 획득 기전권수봉, 배일권, 윤외숙, 이보영, 정석훈, 정연욱, 정태전대한임상미생물학회 · Annals of Clinical Microbiology2005 · 제8권 제1호Clonal Distribution and Its Association With the Carbapenem Resistance Mechanisms of Carbapenem-Non-Susceptible Pseudomonas aeruginosa Isolates From Korean Hospitals이제철, Kim Nayeong, Kim Seong Yeob, Kim Yu Kyung, Ko Seo Yeon, Kwon Ki Tae, Lee Da Eun, Park Seong Yong대한진단검사의학회 · Annals of Laboratory Medicine2024 · 제44권 제5호Genetic Epidemiology and Antimicrobial Susceptibilities of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from a Multicenter Study in KoreaChoi Tae Youn, Choi Young Jin, Chong Yong Pil, Cho Oh-Hyun, Hong Yoon-Kyoung, Jung Jongtak, Kim Mi-Na, Kim Tark, Park Sunghee, Shin Hee Bong대한감염학회 · Infection and Chemotherapy2025 · 제57권 제3호

이 간행물의 다른 논문 (28건)